Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

MiMedx Group Form4 Filing Shows CEO Joseph Capper Bought 200,000 Shares Of Stock At An Average Price Of $6.34/Share

Author: Benzinga Newsdesk | May 05, 2025 10:09am

- SEC Filing

Posted In: MDXG